Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease

Joo Myung Lee1, Ki Hong Choi1, Bon-Kwon Koo2

  • 1Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Combining fractional flow reserve (FFR) and high-risk plaque characteristics (HRPC) improves risk prediction in coronary artery disease. High-risk plaque features significantly increase adverse events in patients with FFR >0.80, suggesting integrated assessment is crucial.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Biomarkers of Cardiovascular Risk

Background:

  • Ischemia and high-risk plaque characteristics (HRPC) are key prognostic factors in coronary artery disease (CAD).
  • Limited data exist on the combined prognostic value of physiological stenosis severity (FFR) and CTA-defined HRPC.

Purpose of the Study:

  • To evaluate the association between physiological stenosis severity (FFR) and coronary CTA-defined HRPC.
  • To assess the prognostic implications of HRPC based on physiological stenosis severity in CAD patients.

Main Methods:

  • Analysis of 772 vessels (299 patients) using coronary CTA and FFR.
  • Assessment of HRPC (e.g., minimum lumen area <4 mm², plaque burden ≥70%, low attenuating plaque, positive remodeling, napkin-ring sign, spotty calcification).
  • Comparison of vessel-oriented composite outcomes (VOCO) at 5 years based on HRPC count and FFR categories.

Main Results:

  • Lesions with ≥3 HRPC decreased significantly as FFR values increased (p<0.001).
  • Both FFR and HRPC count were associated with VOCO risk (p=0.008 and p=0.023, respectively).
  • In the FFR >0.80 group, ≥3 HRPC lesions had higher VOCO risk (15.0% vs 4.3%, HR=3.964; p=0.007), independently associated with VOCO.

Conclusions:

  • Physiological stenosis severity and HRPC are closely related and predict clinical events.
  • The prognostic impact of HRPC varies with FFR, being significant only in the FFR >0.80 group.
  • Integrating FFR and HRPC offers superior prognostic stratification, particularly for patients with FFR >0.80.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
400
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
230
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
615
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
343